Open-Label, Phase I, Dose Escalation/Expansion Trial Of The Anti-Sirpa Monoclonal Antibody Bi 770371 In Patients With Advanced Solid Tumours, Alone Or In Combination With The Anti-Pd-1 Monoclonal Antibody Ezabenlimab
BI-770371;Ezabenlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Open-Label, Phase I, Dose Escalation/Expansion Trial Of The Anti-Sirpa Monoclonal Antibody Bi 770371 In Patients With Advanced Solid Tumours, Alone Or In Combination With The Anti-Pd-1 Monoclonal Antibody Ezabenlimab ### Output: BI-770371;Ezabenlimab